Table 1.
Indication | Name (Immunogen) |
Species | Device (Route) |
EP Device or PMED |
Dose | Vaccine Schedule | Vs. NS | NFIS Notes |
---|---|---|---|---|---|---|---|---|
PRRSV [52] | N, Nsp1β, RdRp | Pig | Tropis (ID) | CUY21EDIT | 0.4 mg * | 0, 34 d C: 63 d |
No |
|
Hantavirus (various) [79] | M | Hamster | Tropis (SC, IM) |
PMED | 0.2 mg, 0.42 mg | 0, 4, 8 wk C: 21 wk |
Yes |
|
Poxvirus [77] | 4pox (L1, A27, B5, A33) |
Rabbit | Tropis (ID) Stratis (IM) |
TriGrid | 0.4 mg | 0, 4, 8 wk | Yes |
|
Influenza [76] | HA | Pig | Tropis (ID) | AgilePulse | 0.025 −0.4 mg | 0, 3–4 wk | No |
|
Dengue [80] | TVDV (Pre-M, E) |
NHP | Tropis (ID) Stratis (IM) |
TriGrid | 1 mg, 5 mg |
0, 28, 91 d C: 392 d |
No |
|
* = total dose administered in multiple injections at the same timepoint; NFIS = needle-free injection systems; EP = electroporation; PMED = particle-mediated epidermal delivery; vs. = versus; NS = needle and syringe; PRRSV = porcine reproductive and respiratory syndrome virus; N = nucleocapsid; Nsp = non-structural protein; RdRP = RNA-dependent RNA polymerase; ID = intradermal; d = day; C = challenge; APC = antigen-presenting cell; MLV = modified live virus; M = medium gene segment; SC = subcutaneous; IM = intramuscular; wk = week; HA = hemagglutinin; TVDV = tetravalent dengue vaccine; Pre-M = pre-membrane; E = envelope; NHP = non-human primate; nAb = neutralizing antibodies.